Expert Interview
A Second View: Checking in with a prescriber of Axsome's SUNOSI (Solriamfetol) in treating excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA)
Ticker(s): AXSMInstitution: University of Rochester
- Associate Professor of Neurology and Medicine and Founding Director of the University of Rochester's sleep medicine fellowship.
- Manages 80 patients with excessive daytime sleepiness and has prescribed SUNOSI.
- Research focuses on sleep medicine and menopausal insomnia; Awarded competitive grants from industry, foundational, and federal funding agencies, including the American Academy of Sleep Medicine Foundation and the Department of Defense.
On a scale of 1 to 10 how would you rate SUNOSI as an option for treating narcolepsy?
Added By: sara_adminHow accessible is SUNOSI compared to similar medications on the market?
Added By: sara_adminUnder what circumstances would you prescribe SUNOSI over another medication?
Added By: sara_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
